prussian blue 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definition	Drug id	CAS RN
	4860	14038-43-8

Description:

Molecule

Description

Synonyms:

radiogardase
ferric ferrocyanide
prussian blue
prussian blue insoluble

antidote to thallium poisoning; RN given refers to Fe(+3)[3:4] salt; structure

Molecular weight: 859.24
Formula: C18Fe7N18
CLOGP:
LIPINSKI: None
HAC: None
HDO: None
TPSA: 142.74
ALOGS:
ROTB: None

Drug dosage:

None

ADMET properties:

None

Approvals:

Date	Agency	Company	Orphan
Oct. 2, 2003	FDA	HEYL CHEMISCH

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Source	Code	Description
ATC	V03AB31	VARIOUS ALL OTHER THERAPEUTIC PRODUCTS ALL OTHER THERAPEUTIC PRODUCTS Antidotes
MeSH PA	D000931	Antidotes
MeSH PA	D004396	Coloring Agents
MeSH PA	D020011	Protective Agents
FDA MoA	N0000000087	Chelating Activity
FDA MoA	N0000175356	Ion Exchange Activity
FDA EPC	N0000192801	Decorporation Agent

Drug Use | Suggest Off label Use Form| |View source of the data|

Disease	Relation	SNOMED_ID	DOID
Thallium poisoning	indication	51040009
Radioactive Cesium Decontamination	indication

🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

ID	Source
D05647	KEGG_DRUG
4021413	VANDF
CHEBI:30069	CHEBI
CHEMBL2096629	ChEMBL_ID
C000170	MESH_SUPPLEMENTAL_RECORD_UI
DB06783	DRUGBANK_ID
24902	RXNORM
108209	MMSL
23506	MMSL
d06664	MMSL
007097	NDDF
406451006	SNOMEDCT_US
406452004	SNOMEDCT_US
C0060234	UMLSCUI
2724251	PUBCHEM_CID
TLE294X33A	UNII

Pharmaceutical products:

Product	Category	Ingredients	NDC	Form	Quantity	Route	Marketing	Label
Radiogardase	HUMAN PRESCRIPTION DRUG LABEL	1	58060-002	CAPSULE	500 mg	ORAL	NDA	26 sections